首页> 外文期刊>Biochemistry >Characterization of G protein-coupled receptor regulation in antisense mRNA-expressing cells with reduced arrestin levels.
【24h】

Characterization of G protein-coupled receptor regulation in antisense mRNA-expressing cells with reduced arrestin levels.

机译:具有降低的抑制蛋白水平的反义mRNA表达细胞中G蛋白偶联受体调节的表征。

获取原文
获取原文并翻译 | 示例
           

摘要

Previous studies with overexpressing wild-type or dominant negative nonvisual arrestins have established a role for these proteins in beta2-adrenergic receptor (beta2AR) internalization, desensitization, and resensitization. To validate and extend such findings, we employed an antisense strategy to target the nonvisual arrestins, arrestin-2 and arrestin-3, and determined the associated effects on the regulation of G protein-coupled receptor (GPCR) signaling. HEK293 cells stably expressing antisense constructs targeting arrestin-2 exhibited a selective reduction (approximately 50%) in arrestin-2 levels, while arrestin-3 antisense constructs resulted in reductions (>/=50%) in both arrestin-2 and arrestin-3 levels. Initial analysis of these cells demonstrated that a reduced level of arrestin expression resulted in a significant decrease in the extent of agonist-induced internalization of exogenously expressed beta2ARs, but had no effect on internalization of either m2 or m3 muscarinic acetylcholine receptors. Additional characterization involved assessing the role of arrestins in the regulation of endogenous GPCRs in these cells. Reduced arrestin levels significantly decreased the rate of endogenous beta2AR internalization, desensitization, and resensitization. Further analysis demonstrated that the desensitization of endogenous A2b adenosine and prostaglandin E2-stimulated receptors was also attenuated in cells with reduced arrestin levels. The effects on the beta2-adrenergic, A2b adenosine, and PGE2-stimulated receptors were similar among cell lines that exhibited either a selective reduction in arrestin-2 levels or a reduction in both arrestin-2 and -3 levels. These findings establish the utility of antisense approaches in the examination of arrestin-mediated GPCR regulation.
机译:先前有关过表达野生型或显性阴性非视觉抑制蛋白的研究已经确定了这些蛋白在β2-肾上腺素能受体(β2AR)内在化,脱敏和再敏化中的作用。为了验证和扩展此类发现,我们采用了一种反义策略来靶向非视觉抑制蛋白,restarin-2和restarin-3,并确定了对G蛋白偶联受体(GPCR)信号传导调控的相关影响。稳定表达靶向抑制蛋白2的反义构建体的HEK293细胞表现出抑制蛋白2水平选择性降低(约50%),而抑制蛋白3反义构建体导致抑制蛋白2和抑制蛋白3降低(> / = 50%)水平。这些细胞的初步分析表明,抑制蛋白表达水平的降低导致激动剂诱导的外源表达beta2ARs内在化程度的显着降低,但对m2或m3毒蕈碱型乙酰胆碱受体的内化没有影响。其他表征涉及评估抑制蛋白在这些细胞中内源性GPCR调控中的作用。抑制蛋白水平的降低显着降低了内源性β2AR内在化,脱敏和重新敏化的速率。进一步的分析表明,内源性A2b腺苷和前列腺素E2刺激的受体的脱敏作用在抑制素水平降低的细胞中也减弱了。在β2肾上腺素,A2b腺苷和PGE2刺激的受体之间的作用在细胞系中表现出相似的作用,这些细胞系选择性地抑制了抑制蛋白2的水平,或者抑制蛋白2和-3的水平都降低了。这些发现建立了反义方法在抑制视紫红质介导的GPCR调控中的效用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号